IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Zenith Drugs IPO is a book build IPO listing on NSE EMERGE exchange. The company is based in Indore and caters to Pharmaceutical sector. Gretex Corporate Services is the merchant banker of Zenith Drugs IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 30th September 2023.
Zenith Drugs IPO open date is 19th February 2024 and close date is 22nd February 2024. IPO Allotment Date is 23rd February 2024 and Listing date is 27th February 2024.Zenith Drugs IPO size is Rs 40.68 Cr. crores with IPO price of Rs 79.00 Cr.. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Gretex Corporate Services Limited is the book-running lead manager of the Zenith Drugs IPO. Bigshare Services Private Limited is the Registrar and Market Maker is Gretex Share Broking Private Limited for Zenith Drugs IPO.
Zenith Drugs IPO anchor investors are the below investors. The number of anchor investors in this IPO is 6.
| Anchor Investor Name | No. of shares Allotted | Offer Price (in Rs.) | Amount Invested (in Rs.) |
|---|---|---|---|
| Meru Investment Fund | 377,600.00 | ₹79.00 | ₹29,830,400.00 |
| Moneywise Financial Services | 128,000.00 | ₹79.00 | ₹10,112,000.00 |
| Neomile Growth Fund | 190,400.00 | ₹79.00 | ₹15,041,600.00 |
| Chanakya Opportunities Fund | 128,000.00 | ₹79.00 | ₹10,112,000.00 |
| Vikasa India EIF | 211,200.00 | ₹79.00 | ₹16,684,800.00 |
| Aries Opportunities Fund | 252,800.00 | ₹79.00 | ₹19,971,200.00 |
Zenith Drugs IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Zenith Drugs IPO, based in Indore, operates in the Pharmaceutical sector with a focus on manufacturing high quality and affordable Medicines. The company is launching its SME IPO on the NSE EMERGE exchange, using the Book Building Issue method. Zenith Drugs IPO size is ₹ 40.68 Cr. Crores with fresh issue size of Rs 40.68 Cr. Crores and Offer for sale being Nil.
The IPO allotment date for Zenith Drugs IPO is expected to be 23rd February 2024, after the finalization of basis of allotment. Investors can check Zenith Drugs IPO allotment status on the registrars website, Bigshare Services Private Limited. Zenith Drugs IPO refund dates are 26th February 2024.
Zenith Drugs IPO is expected to be listed on 27th February 2024.
The upper price band for the Zenith Drugs IPO is set at ₹ 79.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Zenith Drugs IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Zenith Drugs IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 22nd February 2024. After submission, funds are blocked until the basis of allotment of Zenith Drugs IPO is finalised.
The merchant banker for Zenith Drugs IPO is Gretex Corporate Services Limited . Gretex Corporate Services Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Zenith Drugs IPO RHP for further details.
The registrar for Zenith Drugs IPO is Bigshare Services Private Limited. Investors can go to Bigshare Services Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Zenith Drugs IPO through their official website or helpline.
Zenith Drugs IPO was subscribed 179.18 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 40.68 Cr.
Avg IPO Size (Sector Based)
:
₹ 23.81 Cr.
Sector: Pharmaceutical
SME IPO so far:
34
Merchant Banker:
Gretex Corporate
SME IPO by BRLM so far:
47
City:
Indore
SME IPO so far:
18
Revenue (annualised):
₹ 138.96 cr.
PE
Ratio:
12.56x
Average Sector PE Ratio: 20.29x
Zenith Drugs IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Zenith Drugs Financial Review Page
Merchant Banker(s) of Zenith Drugs IPO: Gretex Corporate Services Limited
Zenith Drugs IPO subscription was 179.18 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Zenith Drugs IPO listed at a listing price of 105.15 against the offer price of 79.00.
The current market price of Zenith Drugs is 89.60.
Why Us?
